Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of “Buy” by Analysts
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have received a consensus recommendation of “Buy” from the ...
Principal Financial Group Inc. Has $93,000 Stock Holdings in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Principal Financial Group Inc. trimmed its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by ...
pharmaphorum19h
Otsuka, Aurinia claim EU okay for oral lupus nephritis drug
Kidney inflammation caused by SLE is referred to as lupus nephritis (LN), and it is estimated that between 40% and 50% of all SLE patients will develop LN that requires treatment over the course ...